TNF and tuberculosis: The time tuberculosis-free drug use (Fig 3) differed significantly across different TNF inhibitors agents, with a higher likelihood of developing TB at first exposure with ADA versus ETN (p = 0.01) and a shorter time to onset of TB with CZP therapy than with any other TNF inhibitors agent (p < 0.05).